InVivo’s Perrin on Developments in Spinal Cord Injury Treatment

Publication Source: Bloomberg Markets AM

February 14, 2017 — 4:53 PM EST

Bloomberg Markets AM with Pimm Fox and Lisa Abramowicz.

GUEST: Mark Perrin, CEO of InVivo Therapeutics (NVIV), on highlights from the BIO CEO conference, and developments in the company’s spinal cord injury treatment.

Running time 08:00

Listen to the interview here